Cited by 392Lymphoma Diagnosis and TreatmentViral-associated cancers and disordersChronic Lymphocytic Leukemia Research

The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)

Open access

Morton, Lindsay M., Turner, Jennifer J., Cerhan, James R., Linet, Martha S., Treseler, Patrick A., Clarke, Christina A., Jack, Andrew, Cozen, Wendy, Maynadié, Marc, Spinelli, John J., Costantini, Adele Seniori, Rüdiger, Thomas, Scarpa, Aldo, Zheng, Tongzhang, Weisenburger, Dennis D.·2007·Blood

DOI 10.1182/blood-2006-11-051672PMC PMC1924473

Open this paper in CoChat — free account

Abstract

Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathologic schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases–Oncology, Third Edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will probably prove to be critical for elucidating etiologies of the various lymphoid neoplasms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1182/blood-2006-11-051672

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citation
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]
Harris, N. L., Jaffe, E., Stein, H., Pm, B., Jk, C., Cleary, M. L., Delsol, G., Peeters, C., Falini, B., & Gatter, K. C. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,312
Proposals for the Classification of the Acute Leukaemias F rench ‐A merican ‐B ritish (FAB) C o‐operative G roup
Bennett, J. M., Catovsky, D., Mt, D., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,595
World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,614
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
Rosenwald, A., Wright, G. W., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Müller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,832
Self-citation
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,810
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage
The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) · Cancer · doi:10.1002/1097-0142(19820515)49:10 · Cited by 3,051

Show all 58 references

Research works printed but not linked: 4

Percy, 2001, Conversion of neoplasms by topography and morphology from the International Classification of Diseases for Oncology, second edition, to International Classification of Diseases for Oncology, third edition.
Van Holten, 1992, Conversion of neoplasms by topography and morphology from the International Classification of Diseases for Oncology (ICD-O; first edition and field trials) to International Classification of Diseases for Oncology, second edition (ICD-O-2).
Rothman, 1998, Modern Epidemiology
Chiu, 2005, Association of pesticides, smoking, and familial cancer with risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma., Proc Am Assoc Cancer Res, 46, 1307

Sorted by citations

Items 201–300 of 392

Characteristics of Cutaneous Lymphomas in Korea According to the New WHO-EORTC Classification: Report of a Nationwide Study
Han, J. H., Ko, Y. H., Kang, Y. K., Kim, W. S., Kim, Y. J., Kim, I., Kim, H., Min, S. K., Park, C.-K., Park, C.-S., et al. (2014) · Journal of Pathology and Translational Medicine · doi:10.4132/koreanjpathol.2014.48.2.126 · Cited by 21
“With respect to lymphoma subtype and sex, the results of our study were consistent with previous reports.(5,8,9) Specifically, we observed a male predominance for the majority of lympho ma subtypes, especially BPDC neoplasm and T lymphoblastic lymphoma, and a female predominance for SPTCL.”
Result
Lenalidomide alone or in combination with chemotherapy treatment for subtypes of diffuse large B cell lymphoma: a systematic review and meta-analysis.
Fang, C., Zhu, D., Dong, H., Ji, M., Wu, J., Xu, X., Cheng, G., Wu, C., & Jiang, J. (2015) · PubMed Central · Cited by 21
Epidemiology of Hematologic Malignancies
Batista, J. L., Birmann, B. M., & Epstein, M. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_29 · Cited by 21
“uniformity in the investigation of lymphoma subtypes in epidemiologic research [11, 12].”
Background
Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony‐stimulating factors in older patients with non‐Hodgkin lymphoma
Calip, G. S., Moran, K. M., Sweiss, K. I., Patel, P. R., Wu, Z., Adimadhyam, S., Lee, T. A., Ko, N. Y., Quigley, J. G., & Chiu, B. C. ‐. (2018) · Cancer · doi:10.1002/cncr.31914 · Cited by 21
Association of Alcohol Intake and Smoking with Malignant Lymphoma Risk in Japanese: A Hospital-Based Case-Control Study at Aichi Cancer Center
Kanda, J., Matsuo, K., Kawase, T., Suzuki, T., Ichinohe, T., Seto, M., Morishima, Y., Tajima, K., & Tanaka, H. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0050 · Cited by 20
“The incidence of follicular lymphoma and marginal zone lymphoma was high, whereas that of chronic lymphocytic leukemia/small lymphocytic lymphoma and Hodgkin's lymphoma was extremely low in our cohort compared with western countries (1, 17).”
BackgroundResult
Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000–2018
Morton, L. M., Curtis, R. E., Linet, M. S., Schonfeld, S. J., Advani, P. G., Dalal, N., Sasse, E. C., & Dores, G. M. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102060 · Cited by 20
Self-citation
Dietary vitamin D and risk of non-Hodgkin lymphoma: the multiethnic cohort
Erber, E., Maskarinec, G., Lim, U., & Kolonel, L. N. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509992029 · Cited by 20
“NHL was classified into the most common subtypes according to the adaptation of the WHO classification for epidemiologic studies((8,9)).”
Method
Primary Extranodal Non-Hodgkin Lymphoma of the Head and Neck in Patients with Acquired Immunodeficiency Syndrome: A Clinicopathologic Study of 24 Patients in a Single Hospital of Infectious Diseases in Argentina
Villafañe, M. F., Bistmans, A., Narbaitz, M., Gilardi, L., & Corti, M. (2014) · International Archives of Otorhinolaryngology · doi:10.1055/s-0034-1373782 · Cited by 20
Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma
Valencia-Hipόlito, A., Hernández-Atenógenes, M., Vega, G. G., Maldonado-Valenzuela, A., Ramon, G., Mayani, H., Peña-Alonso, Y. R., Martı́nez-Maza, O., Méndez-Tenorio, A., Huerta‐Yépez, S., et al. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.848437 · Cited by 20
Expected long-term survival of older patients diagnosed with non-Hodgkin lymphoma in 2008–2012
Pulte, D. D., Gondos, Á., & Brenner, H. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.08.006 · Cited by 20
“Follicular lymphomas (apart from pediatric and cutaneous) are categorized as a single group in the Interlymph system that corresponds to the ICD-O-3 histology codes used in SEER for follicular lymphoma [12].”
BackgroundMethod
Nurses’ Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic
Birmann, B. M., Barnard, M. E., Bertrand, K. A., Bao, Y., Crous‐Bou, M., Wolpin, B. M., Vivo, I. D., & Tworoger, S. S. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303337 · Cited by 22
Relations Between Residential Proximity to EPA-Designated Toxic Release Sites and Diffuse Large B-Cell Lymphoma Incidence
Bulka, C. M., Nastoupil, L. J., Koff, J. L., Bernal‐Mizrachi, L., Ward, K. C., Williams, J. N., Bayakly, A. R., Switchenko, J. M., Waller, L. A., & Flowers, C. R. (2016) · Southern Medical Journal · doi:10.14423/smj.0000000000000545 · Cited by 20
“05 (National Cancer Institute, Bethesda, MD) was used to access the SEER 13 Registries Database and standardize the DLBCL incidence rates from Georgia to national DLBCL incidence rates.(16) Age-, sex-, and race-specific crude DLBCL incidence rates were obtained for the 1999–2008 period to standardize Georgia census tr…”
Method
Alcohol consumption and risk of lymphoid and myeloid neoplasms: Results of the Netherlands cohort study
Heinen, M. M., Verhage, B. A. J., Schouten, L. J., Goldbohm, R. A., Schouten, H. C., & van den Brandt, P. A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28175 · Cited by 19
“Using the histology codes provided by the cancer registries, we subdivided the lymphoid neoplasms into categories based on the hierarchical groupings of the International Lymphoma Epidemiology Consortium (InterLymph) nested classification (Table 1).(29) This classification is based on the World Health Organization (WH…”
Method
The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry
Dandoit, M., Mounier, M., Guy, J., Petrella, T., Girard, S., Casasnovas, O., Martin, L., Bonnetain, F., & Maynadié, M. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.956315 · Cited by 19
Self-citation
Medical History, Lifestyle, Family History, and Occupational Risk Factors for Adult Acute Lymphocytic Leukemia: The InterLymph Non-Hodgkin Lymphoma Subtypes Project
Skibola, C. F., Slager, S. L., Berndt, S. I., Lightfoot, T., Sampson, J. N., Morton, L. M., & Weisenburger, D. D. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu009 · Cited by 19
“Cases were classified according to the World Health Organization classification (15,16) using guidelines from the InterLymph Pathology Working Group (17,18).”
MethodSelf-citation
A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non‐Hodgkin lymphoma
Chiu, Y., Bertrand, K. A., Zhang, S., Laden, F., Epstein, M. M., ROSNER, B. A., Chiuve, S. E., Campos, H., Giovannucci, E. L., Chavarro, J. E., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31602 · Cited by 18
“Baseline BMI(1), kg/m(2) 24 (23, 28) 25 (23, 30) 25 (23, 27) 24 (22, 25) 25 (23, 27) 25 (23, 28)”
Environmental pesticide exposure and non-Hodgkin lymphoma survival: a population-based study
Poh, C., McPherson, J. D., Tuscano, J. M., Li, Q., Parikh‐Patel, A., Vogel, C. F. A., Cockburn, M., & Keegan, T. H. M. (2022) · BMC Medicine · doi:10.1186/s12916-022-02348-7 · Cited by 18
Diesel Exhaust Exposure and Cause-Specific Mortality in the Diesel Exhaust in Miners Study II (DEMS II) Cohort
Koutros, S., Graubard, B. I., Bassig, B. A., Vermeulen, R. C. H., Appel, N., Hyer, M., Stewart, P. A., & Silverman, D. T. (2023) · Environmental Health Perspectives · doi:10.1289/ehp12840 · Cited by 18
Prognostic value of some inflammatory markers in patients with lymphoma
Anber, N. H., El-Sebaie, A. H., Darwish, N. H. E., Mousa, S. A., & Shamaa, S. S. A. (2019) · Bioscience Reports · doi:10.1042/bsr20182174 · Cited by 18
Pleiotropy of Cancer Susceptibility Variants on the Risk of Non-Hodgkin Lymphoma: The PAGE Consortium
Lim, U., Kocarnik, J., Bush, W. S., Matise, T. C., Caberto, C., Park, S. L., Carlson, C. S., Deelman, E., Duggan, D. J., Fesinmeyer, M. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089791 · Cited by 17
“Also, heterogeneity in the SNP-cancer associations across common NHL subtypes (DLBCL, FL, CLL/SLL) was examined in the MEC, where all subtypes were ascertained, by performing polytomous logistic regression using common controls.”
MethodInfluential
Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma
Rossi, C., Jegu, J., Mounier, M., Dandoit, M., Colonna, M., Daubisse‐Marliac, L., Trétarre, B., Ganry, O., Guizard, A., Bara, S., et al. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1007505 · Cited by 17
Self-citation
Investigation of Epstein–Barr Virus as a Potential Cause of B-Cell Non-Hodgkin Lymphoma in a Prospective Cohort
Roos, A. J. D., Martı́nez-Maza, O., Jerome, K. R., Mirick, D. K., Kopecky, K. J., Madeleine, M. M., Magpantay, L. I., Edlefsen, K. L., & LaCroix, A. Z. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0240 · Cited by 17
“B-cell NHL cases were further grouped on the basis of the World Health Organization and the International Lymphoma Epidemiology Consortium (InterLymph) guidelines (26, 27), including 142 chronic lymphocytic leukemia/small lymphocytic lymphoma/prolymphocytic leukemia (CLL/SLL/PLL; 28.”
Method
Lymphoma and multiple myeloma in cohorts of persons exposed to ionising radiation at a young age
Little, M. P., Wakeford, R., Zablotska, L. B., Borrego, D., Griffin, K., Allodji, R. S., de Vathaire, F., Lee, C., Brenner, A. V., Miller, J. S., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01284-4 · Cited by 17
Self-citation
Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies
Epstein, M. M., ROSNER, B. A., Breen, E. C., Batista, J. L., Giovannucci, E. L., Magpantay, L. I., Aster, J. C., Rodig, S. J., Bertrand, K. A., Laden, F., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.183236 · Cited by 17
“Study pathologists (JCA, SJR) classified NHL histological subtype(19) according to World Health Organization(20,21) and International Lymphoma Epidemiology (InterLymph) Consortium guidelines.(22,23) We analyzed common B-cell (B-)NHL subtypes individually [diffuse large”
Method
Menopausal estrogen therapy and non‐ H odgkin's lymphoma: A post‐hoc analysis of women's health initiative randomized clinical trial
Kato, I., Chlebowski, R. T., Hou, L., Wactawski‐Wende, J., Ray, R. M., Abrams, J., Bock, C. H., Desai, P. M., & Simon, M. S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29819 · Cited by 16
Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial
Wade, R. L., Bernardo, M. C. D., Richards, S. M., Rossi, D., Crowther-Swanepoel, D., Gaïdano, G., Oscier, D., Catovsky, D., & Houlston, R. S. (2011) · Haematologica · doi:10.3324/haematol.2011.043471 · Cited by 18
“Chronic lymphocytic leukemia (CLL) is the commonest lymphoid malignancy in Western populations.(1,2) While staging systems (Binet, Rai) are clinically useful for predicting prognosis and treatment requirements in CLL(3) there is variability in the outcome of patients who apparently have the same stage of disease.”
Background
Risk factors for non‐Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population‐based case‐control study
Chang, C. M., WANG, S. S., Davé, B. J., Jain, S., Vasef, M. A., Weisenburger, D. D., Cozen, W., Davis, S., Severson, R. K., Lynch, C. F., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25717 · Cited by 15
Self-citation
To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes
Koff, J. L., Chihara, D., Phan, A., Nastoupil, L. J., Williams, J. N., & Flowers, C. R. (2015) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-015-0267-0 · Cited by 15
Adaptive Immunity
Merlo, L. M. F., & Mandik‐Nayak, L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00003-8 · Cited by 15
Body size and risk of Hodgkin’s lymphoma by age and gender: a population-based case–control study in Connecticut and Massachusetts
Li, Q., Chang, E. T., Bassig, B. A., Dai, M., Qin, Q., Gao, Y., Zhang, Y., & Zheng, T. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0100-1 · Cited by 15
“However, we excluded the latter from our analyses, because the nodular lymphocyte-predominant subtype is considered biologically and clinically separate from classical subtypes [25].”
Self-citation
Persistent infection by HCV and EBV in peripheral blood mononuclear cells and risk of non-Hodgkin's lymphoma
Richiardi, L., Marco, L. D., Gillio‐Tos, A., Merletti, F., Fiano, V., Palli, D., Masala, G., Agnoli, C., Tagliabue, G., Panico, S., et al. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.07.014 · Cited by 15
The Challenges of Epidemiologic Research in Non-Hodgkin Lymphoma
Evens, A. M. (2008) · JAMA · doi:10.1001/jama.2008.589 · Cited by 15
Trends in excess mortality in follicular lymphoma at a population level
Mounier, M., Bossard, N., Belot, A., Remontet, L., Iwaz, J., Dandoit, M., Girard‐Boulanger, S., Herry, A., Woronoff, A., Casasnovas, O., et al. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12403 · Cited by 14
“For lymphoma, the new classification was largely based on the Revised European American Lymphoma Classification published in 1994 (32), and the incidence of FL was only slightly affected by changes in cancer classification.”
MethodSelf-citation
Nutrients and Genetic Variation Involved in One-Carbon Metabolism and Hodgkin Lymphoma Risk: A Population-based Case-Control Study
Kasperzyk, J. L., Chang, E. T., Birmann, B. M., Kraft, P., Zheng, T., & Mueller, N. E. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr190 · Cited by 14
“We excluded the latter from our analyses, because the nodular lymphocyte-predominant subtype is considered biologically and clinically separate from classical subtypes (24).”
ResultSelf-citation
Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy
Desai, M., Newberry, K. J., Romaguera, J. E., Zhang, L., Ou, Z., & Wang, M. L. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-55 · Cited by 14
“FL is the most common indolent NHL [25,26].”
Background
Malaria and risk of lymphoid neoplasms and other cancer: a nationwide population-based cohort study
Wyss, K., Granath, F. N., Wångdahl, A., Djärv, T., Fored, M., Nauclér, P., & Färnert, A. (2020) · BMC Medicine · doi:10.1186/s12916-020-01759-8 · Cited by 14
“Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, Stagnaro E, Willett EV, Franceschi S, La Vecchia C, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph).”
MethodInfluential
Primary Lymphoma of Nasal Cavity and Paranasal Sinuses
Azarpira, N., Ashraf, M. J., Monabati, A., Makarempour, A., Khademi, B., Hakimzadeh, A., Abedi, E., & Valibeigi, B. (2012) · Laboratory Medicine · doi:10.1309/lmkh083qcxfuuigs · Cited by 14
Resolving uncertainty in the spatial relationships between passive benzene exposure and risk of non-Hodgkin lymphoma
Switchenko, J. M., Bulka, C. M., Ward, K. C., Koff, J. L., Bayakly, A. R., Ryan, P. B., Waller, L. A., & Flowers, C. R. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.01.008 · Cited by 14
The role of primary lymph node sites in survival and mortality prediction in Hodgkin lymphoma: a SEER population‐based retrospective study
Ebied, A., Huan, V. T., Makram, O. M., Sang, T. K., Ghorab, M. M. E., Ngo, H. T., Iraqi, A., Kamel, M. G., Đăng, T. N., Vuong, N. L., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1280 · Cited by 14
Extranodal involvement of diffuse large B-cell lymphoma in the head and neck: An indicator of good prognosis
Lee, D. Y., Kang, K. S., Jung, H., Park, Y. M., Cho, J., Baek, S., Kwon, S. Y., Jung, K., & Woo, J. (2018) · Auris Nasus Larynx · doi:10.1016/j.anl.2018.05.006 · Cited by 14
Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes
Herr, M. M., Schonfeld, S. J., Dores, G. M., Engels, E. A., Tucker, M. A., Curtis, R. E., & Morton, L. M. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019030924 · Cited by 14
“We included the following specific NHL subtypes, defined by International Classification of Diseases for Oncology, third edition (ICD-O-3), morphology codes and grouped according toWorld Health Organization classification: DLBCL (ICD-O-3 codes M9678-9680, 9684 [B-cell immunophenotype only], 9688, 9712, 9737-9738), FL…”
MethodSelf-citation
Nutritional factors and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort
Leo, Q. J. N., Ollberding, N. J., Wilkens, L. R., Kolonel, L. N., Henderson, B. E., Marchand, L. L., & Maskarinec, G. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.139 · Cited by 14
Relationship between ambient ultraviolet radiation and Hodgkin lymphoma subtypes in the United States
Bowen, E. M., Pfeiffer, R. M., Linet, M. S., Liu, W. T., Weisenburger, D. D., Freedman, D. M., & Cahoon, E. K. (2016) · British Journal of Cancer · doi:10.1038/bjc.2015.383 · Cited by 13
“Relationship between ambient ultraviolet radiation and Hodgkin lymphoma subtypes in the United States”
Self-citation
Unraveling the interactions between environmental factors and genetic polymorphisms in non-Hodgkin lymphoma risk
WANG, S. S., & Nieters, A. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.194 · Cited by 13
Neoplasms of the lungs, airways, and pleura
Hansell, D. M., Lynch, D. A., McAdams, H. P., & Bankier, A. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7234-3496-2.00018-x · Cited by 13
Diagnostic Performance and Safety of Ultrasound‐Guided Core Needle Biopsy for Diagnosing Lymphoma: A Systematic Review and Meta‐Analysis
Kwon, Y., & Lee, M. K. (2025) · Cancer Medicine · doi:10.1002/cam4.70414 · Cited by 12
Race‐specific features and outcomes of nodular lymphocyte‐predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base
Olszewski, A. J., Shrestha, R. K., & Cook, N. M. (2015) · Cancer · doi:10.1002/cncr.29527 · Cited by 12
“NLPHL was identified by the International Classification of Diseases for Oncology, 3rd Edition histology code 9659/3, according to the International Lymphoma Epidemiology Consortium (InterLymph) hierarchical classification of lymphoid neoplasms for epidemiologic research.(18) Stage was categorized as early (stage IA/B…”
Method
Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites
Wang, C., Li, W., Liu, C., He, H., & Bai, O. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.12.004 · Cited by 12
Relative frequency and survival of primary cutaneous lymphomas: a retrospective analysis of 98 patients
Liu, J., Yu, X., Liu, Y., Jin, H., Ma, D., Qu, T., Wang, T., & Sun, Q. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20132424 · Cited by 12
The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population
Zhong, C., Gragert, L. A., Maiers, M. J., Hill, B. T., Garcia-Gomez, J. F., Gendzekhadze, K., Senitzer, D., Song, J. Y., Weisenburger, D. D., Goldstein, L., et al. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1617858 · Cited by 12
“A total of 1977 patients with histologically confirmed NHL per Interlymph/WHO classification [29,30] and 15,020 donors were identified between January 1995 and October 2015.”
BackgroundSelf-citation
Primary Diffuse Large B-Cell Lymphoma of the Urinary Tract: A Population-Based Analysis
Liu, Z., Yang, L., Song, P., Fang, K., Zhou, J. W., Peng, Z., & Dong, Q. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.609882 · Cited by 12
“The most commonly diagnosed non-Hodgkin’s lymphoma (NHL) subtype is diffuse large B-cell lymphoma (DLBCL), which accounts for approximately 30% of NHL cases (1).”
Background
Epidemiology and management of lymphoma in low‐income countries
Zucca, E., Rohatiner, A., MAGRATH, I. T., & Cavalli, F. (2010) · Hematological Oncology · doi:10.1002/hon.945 · Cited by 12
“These observations led the International Lymphoma Epidemiology Consortium (InterLymph) to propose a nested classification of lymphoid neoplasms (based on the WHO classification) to facilitate the analysis of lymphoma subtypes in epidemiologic research [3].”
Method
Association of Obesity and Type 2 Diabetes with Non-Hodgkin Lymphoma: The Multiethnic Cohort
Maskarinec, G., Brown, S., Lee, J., Bogumil, D. D., Walsh, C. P., Haiman, C. A., Setiawan, V. W., Shvetsov, Y. B., & Marchand, L. L. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-0565 · Cited by 11
Clinical manifestations of diffuse large B-cell lymphoma that exhibits initial symptoms in the maxilla and mandible: a single-center retrospective study
Michi, Y., Harada, H., Oikawa, Y., Okuyama, K., Kugimoto, T., Kuroshima, T., Hirai, H., Mochizuki, Y., Shimamoto, H., Tomioka, H., et al. (2022) · BMC Oral Health · doi:10.1186/s12903-022-02056-x · Cited by 11
“Abbreviations DLBCL: Diffuse large B‑cell lymphoma; ML: Malignant lymphoma; ECOG: Eastern Cooperative Oncology Group; CT: Computed tomography; ADC: Apparent diffusion coefficient; MRI: Magnetic resonance imaging; FDG: Fluorodeoxyglucose; PET/CT: Positron emission tomography–computed tomography; SUVmax: Maximum standar…”
Background
Computer-Assisted Quantitative Evaluation of Therapeutic Responses for Lymphoma Using Serial PET/CT Imaging
Gao, X., Xue, Z., Xing, J., Lee, D., Gottschalk, S. M., Heslop, H. E., Bollard, C. M., & Wong, S. T. C. (2010) · Academic Radiology · doi:10.1016/j.acra.2009.10.026 · Cited by 11
“This diverse group of diseases is broadly classified as Hodgkin disease or non-Hodgkin’s lymphoma with several subclassification schemes to describe various cellular, genetic, and clinical subtypes (2).”
Background
Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium
Kane, E. V., Skibola, C. F., Bracci, P. M., Cerhan, J. R., Costas, L., Smedby, K. E. E., Holly, E. A., Maynadié, M., Novak, A. J., Lightfoot, T. J., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1355 · Cited by 11
Self-citation
Weight change trends and overall survival in United States veterans with follicular lymphoma treated with chemotherapy
Xiao, D. Y., Luo, S., O’Brian, K., Liu, W., & Carson, K. R. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1217526 · Cited by 11
“A retrospective cohort of patients with a new diagnosis of FL between October 1, 1998 and September 30, 2010 with follow up until October 17, 2014 was assembled from the Veteran’s Health Administration Central Cancer Registry (VACCR) based on the InterLymph classification system (International Classification of Diseas…”
MethodInfluential
Case-control investigation of occupational exposure to chlorinated solvents and non-Hodgkin’s lymphoma
Callahan, C. L., Stewart, P. A., Friesen, M. C., Locke, S. J., Roos, A. J. D., Cerhan, J. R., Severson, R. K., Rothman, N., & Purdue, M. P. (2018) · Occupational and Environmental Medicine · doi:10.1136/oemed-2017-104890 · Cited by 11
Self-citation
Association of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis.
Dai, Z.-M., He, A., Zhang, W., Liu, J., Cao, X.-M., Chen, Y., Ma, X., Zhao, W., & Dai, Z.-J. (2014) · PubMed Central · Cited by 11
Cardiovascular mortality trends in non-Hodgkin’s lymphoma: a population-based cohort study
Kamel, M. G., El‐Qushayri, A. E., Thach, T. Q., & Huy, N. T. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1409626 · Cited by 11
“miological research based on the 2008 WHO classification [35] and the third edition of the International Classification of Diseases for Oncology coding system [36].”
Method
The Small Round Blue Cell Tumors of the Sinonasal Area: Histological and Immunohistochemical Findings
Ashraf, M. J., Beigomi, L., Azarpira, N., Geramizadeh, B., Khademi, B., Hakimzadeh, A., & Abedi, E. (2013) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.4735 · Cited by 11
“The second most common malignancy of the sinonasal tract following SCC is malignant lymphoma (13, 14).”
BackgroundInfluential
Pigmentary traits, sun exposure, and risk of non‐Hodgkin’s lymphoma/chronic lymphocytic leukemia: A study within the French E3N prospective cohort
Garcin, L., Gelot, A., Gomez, R., Gusto, G., Boutron‐Ruault, M., Kvaskoff, M., Severi, G., & Besson, C. (2020) · Cancer Medicine · doi:10.1002/cam4.3586 · Cited by 10
Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma
Atar, O., Ram, R., Avivi, I. M., Amit, O., Vitkon, R., Luttwak, E., On, Y. B., & Gidron, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030908 · Cited by 10
“Introduction Diffused large B-cell lymphoma (DLBCL) is considered the most common type of non-Hodgkin’s lymphoma worldwide [1].”
Background
Prediagnostic Circulating Polyomavirus Antibody Levels and Risk of Non-Hodgkin Lymphoma
Teras, L. R., Rollison, D. E. M., Pawlita, M., Michel, A., Blase, J. L., Willhauck‐Fleckenstein, M., & Gapstur, S. M. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1125 · Cited by 10
“NHL subtypes were categorized using INTERLYMPH guidelines (6).”
Method
Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review
Brandenburg, N. A., Phillips, S., Wells, K. E., Woodcroft, K. J., Amend, K. L., Enger, C. L., & Oliveria, S. A. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4711 · Cited by 10
T‐cell lymphoblastic lymphoma in children, adolescents and young adults
Vrugt, M. T., Newman, H. M., Teachey, D. T., & Burkhardt, B. (2025) · British Journal of Haematology · doi:10.1111/bjh.70053 · Cited by 9
Dietary exposure to polychlorinated biphenyls (PCB) and risk of Non-Hodgkin's lymphoma: Evidence from the French E3N prospective cohort
Lemaître, M., Frénoy, P., Fiolet, T., Besson, C., & Mancini, F. R. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111005 · Cited by 9
Residential cancer cluster investigation nearby a Superfund Study Area with trichloroethylene contamination
Press, D. J., McKinley, M. A., Deapen, D., Clarke, C. A., & Gomez, S. L. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0734-5 · Cited by 9
Self-citation
Exposure to pesticides and risk of Hodgkin lymphoma in an international consortium of agricultural cohorts (AGRICOH)
Kim, J., Leon, M. E., Schinasi, L. H., Baldi, I., Lebailly, P., Freeman, L. E. B., Nordby, K.-C., Ferro, G., Monnereau, A., Brouwer, M., et al. (2023) · Cancer Causes & Control · doi:10.1007/s10552-023-01748-1 · Cited by 9
Farm Characteristics, Allergy Symptoms, and Risk of Non-Hodgkin Lymphoid Neoplasms in the Agricultural Health Study
Hofmann, J. N., Hoppin, J. A., Lynch, C. F., Poole, J. A., Purdue, M. P., Blair, A. E., Alavanja, M. C. R., & Freeman, L. E. B. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1246 · Cited by 9
“NHL and the following B-cell subtypes were defined according to the classifications proposed by the Pathology Working Group of the International Lymphoma Epidemiology Consortium (20): diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), and…”
Method
Lack of survival improvement in patients with peripheral T-cell lymphoma: a Surveillance, Epidemiology, and End Results analysis
Morgensztern, D., Walker, G. R., Koniaris, L. G., & Lossos, I. S. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.542596 · Cited by 9
“This classification has been recently recommended by the World Health Organization for group standardization during epidemiological research of lymphoma subtypes [11].”
Method
Walking, Writing and Performance: Autobiographical Texts
Heddon, D. E., Lavery, C., & Smith, P. J. (2009) · Cited by 9
Are epidemiological data on lymphoma incidence comparable? Results from an application of the coding recommendations of WHO, InterLymph, ENCR and SEER to a cancer registry dataset
Adzersen, K. H., Friedrich, S., & Becker, N. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2017-z · Cited by 9
Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset
Little, M. P., Mai, J. Z., Fang, M., Chernyavskiy, P., Kennerley, V., Cahoon, E., Cockburn, M., Kendall, G., & Kimlin, M. G. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02629-3 · Cited by 7
“NHL was de ﬁ ned using ‘ 2(a)2 Mature Non-Hodgkin lymphoma, B-cell ’ , ‘ 2(a)3 Non-Hodgkin lymphoma, B-cell, NOS ‘ , and ‘ 2(b)2 Mature Non-Hodgkin lymphoma, T-cell ’ , or with a ICD-O-3 histology code of ‘ 9832 ’ [24].”
Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis
Boyle, T., Kleinstern, G., Bracci, P. M., Cerhan, J. R., Benavente, Y., Casabonne, D., Chiu, B. C. ‐., Habermann, T. M., Holly, E. A., Liebow, M., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34266 · Cited by 8
“NHL subtype was classified according to Morton et al.21 Only studies with at least 20 cases of a subtype were included in that subtypespecific analyses, and only subtypes with at least 200 cases were analysed as separate subtypes.”
MethodSelf-citation
Single-cell transcriptome analysis reveals stem cell-like subsets in the progression of Waldenström’s macroglobulinemia
Qiu, Y., Wang, X., Yao, Y., Si, Y., Wang, X., Jia, M.-N., Zhou, D., Yu, J., Cao, X., & Li, J. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00382-6 · Cited by 8
“Waldenström’s macroglobulinemia (WM) is an uncommon lymphoproliferative disorder characterized by monoclonal immunoglobulin M protein production and bone marrow infiltration by lymphoplasmacstetytoid cells [1].”
Background
Association between cumulative airborne dioxin exposure and non-Hodgkin's lymphoma risk in a nested case-control study within the French E3N cohort
Gaspard, E., Frénoy, P., Praud, D., Coudon, T., Grassot, L., Assi, A. A., Fervers, B., Gelot, A., Mancini, F. R., Severi, G., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.167330 · Cited by 8
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection
Arcaini, L., Pascutto, C., Passamonti, F., Bruno, R., Merli, M., Rizzi, S., Orlandi, E. M., Astori, C., Rattotti, S., Paulli, M., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24162 · Cited by 8
Subtype of dietary fat in relation to risk of Hodgkin lymphoma: a population-based case–control study in Connecticut and Massachusetts
Gao, Y., Li, Q., Bassig, B. A., Chang, E. T., Dai, M., Qin, Q., Zhang, Y., & Zheng, T. (2013) · Cancer Causes & Control · doi:10.1007/s10552-012-0136-2 · Cited by 8
“We excluded the latter from our analyses, because the nodular lymphocyte-predominant subtype was considered biologically and clinically separate from classical subtypes [20].”
ResultSelf-citation
A prospective analysis of blood donation history and risk of non-Hodgkin lymphoma
Ishii, K., Birmann, B. M., Zhang, X., Giovannucci, E. L., & Bertrand, K. A. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1091928 · Cited by 9
“Major histologic subtypes of NHL were determined according to the World Health Organization (WHO) classification of lymphomas [15] based on morphology and immunophenotype information available in medical records and the pathology report and consistent with recent International Lymphoma Epidemiology (InterLymph) Consor…”
Method
Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study
Wadé, N. B., Chang, C. M., Conti, D. V., Millstein, J., Skibola, C. F., Nieters, A., WANG, S. S., de Sanjosé, S., Kane, E. V., Spinelli, J. J., et al. (2020) · Cancer Causes & Control · doi:10.1007/s10552-020-01266-4 · Cited by 8
Self-citation
Serum concentrations of per- and polyfluorinated substances and risk of B-cell non-Hodgkin lymphoma
Rhee, J., Koponen, J. M., Sampson, J. N., Keil, A. P., Ward, M. H., Hofmann, J. N., Huang, W., Silverman, D. T., Rantakokko, P., & Purdue, M. P. (2024) · Environment International · doi:10.1016/j.envint.2024.109058 · Cited by 7
Carbaryl use and incident cancer in the Agricultural Health Study: an updated analysis
Erickson, P. A., Andreotti, G., Remigio, R. V., Ward, M. H., Parks, C. G., Sandler, D. P., Albert, P. S., Barry, K. H., Hofmann, J. N., & Freeman, L. E. B. (2025) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2025.114615 · Cited by 8
Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy
Ermann, D. A., Vardell, V. A., Shah, H., Fitzgerald, L. A., Tao, R., Gaffney, D. K., Stephens, D. M., & Hu, B. (2023) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2023.09.006 · Cited by 7
Coffee consumption and risk of non-Hodgkin’s lymphoma: evidence from the Italian multicentre case–control study
On behalf of the Working Group for the Epidemiology of Hematolymphopoietic Malignancies in Italy, Parodi, S., Merlo, D. F., & Stagnaro, E. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0909-8 · Cited by 7
The relationship among primary anatomic subsite and risk and distribution of second malignant neoplasms in patients with stage I/II diffuse large B-cell lymphoma: An analysis of the surveillance, epidemiology, and end results database
Yin, X., Xu, A., Huang, Z., Fan, F., Wang, Y., Chen, L., Cui, G., Hu, Y., & Sun, C. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101106 · Cited by 7
“The reasons might be that:(1) ecause of improved therapies, patients now survived longer.”
BackgroundInfluential
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS
WANG, S. S., Vajdic, C. M., Linet, M. S., Slager, S. L., Voutsinas, J. M., Nieters, A., Casabonne, D., Cerhan, J. R., Cozen, W., Alarcón, G. S., et al. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0875 · Cited by 7
Self-citation
Short- and Long-term weight changes among United States veterans with diffuse large B-cell lymphoma treated with CHOP chemotherapy
O’Brian, K., Luo, S., Ganti, A., Riedell, P. A., Lynch, R. C., Roop, R. P., Sanfilippo, K. M., Liu, W., Colditz, G. A., & Carson, K. R. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1056183 · Cited by 7
Impact of Routine Surveillance Imaging on Outcomes of Patients With Diffuse Large B-Cell Lymphoma After Autologous Hematopoietic Cell Transplantation
Epperla, N., Shah, N., Hamadani, M., Richardson, K. J., Kapke, J. T., Patel, A., Teegavarapu, S. P., Carrum, G., Hari, P., Pingali, S. R., et al. (2016) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2016.08.018 · Cited by 7
Animal farming and the risk of lymphohaematopoietic cancers: a meta-analysis of three cohort studies within the AGRICOH consortium
El‐Zaemey, S., Schinasi, L. H., Ferro, G., Tual, S., Lebailly, P., Baldi, I., Nordby, K.-C., Kjærheim, K., Schüz, J., Monnereau, A., et al. (2019) · Occupational and Environmental Medicine · doi:10.1136/oemed-2018-105655 · Cited by 7
Rotating Nightshift Work and Hematopoietic Cancer Risk in US Female Nurses
Zhang, Y., Birmann, B. M., Papantoniou, K., Zhou, E. S., Erber, A. C., & Schernhammer, E. S. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz106 · Cited by 7
Red blood cell membrane trans fatty acid levels and risk of non-Hodgkin lymphoma: a prospective nested case–control study
Korat, A. V. A., Chiu, Y., Bertrand, K. A., Zhang, S., Epstein, M. M., ROSNER, B. A., Chiuve, S. E., Campos, H., Giovannucci, E. L., Chavarro, J. E., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa251 · Cited by 7
“Histologic subtypes were determined according to the WHO classification of lymphomas and categorized as recommended by the International Lymphoma Epidemiology (InterLymph) Consortium Pathology Working Group (22, 23), as described previously (24).”
Method
The Epidemiology of Obesity and Hematologic Malignancies
Teras, L. R., & Patel, A. V. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2403-1_1 · Cited by 7
CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma
Galicia, N., Dégano, R. M., Díez, P., González‐González, M., Góngora, R., Ibarrola, N., & Fuentes, M. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1307106 · Cited by 7
Low grade, indolent lymphomas of the head and neck: Comparative toxicity of standard versus very low dose radiation therapy
Chelius, M. R., Chau, K., Yang, J. C., Hajj, C., Imber, B. S., & Yahalom, J. (2021) · Hematological Oncology · doi:10.1002/hon.2865 · Cited by 6
“Across all lymphomas, approximately 30% are indolent non‐Hodgkin lymphomas (iNHLs).(3) Current National Comprehensive Cancer Network (NCCN) guidelines recommend radiation therapy (RT) in the treatment of indolent lymphomas at doses of 24–30 Gy to the involved site.”
Background
Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma
Kim, D. Y., Nam, J., Chung, J.-S., Jeon, B. E., Lee, J. H., Jo, J., Kim, S.-W., & Shin, H. (2021) · Cancer Research and Treatment · doi:10.4143/crt.2021.944 · Cited by 6
“Multiple studies have shown that advanced disease status is a significant predictor of FN in various cancers, including NHL and breast, ovarian, lung, colorectal, and prostate cancers [23,24].”
Background
Prognostic value of FOXP3 and TGF-β expression in both peripheral blood and lymph nodes in patients with B-Non Hodgkin’s lymphoma
Sayed, L. H. E., Ghoneim, H. M., Rahman, M. A. A., Mohamed, B., Rawash, S. N. A., & Elkerm, Y. (2013) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2013.07.003 · Cited by 6
“The most common B-cell lymphoma subtypes include follicular lymphoma, diffuse large B-cell lymphoma, marginal zone lymphoma and mantle cell lymphoma.(26) The clinical course of this disease is variable and the molecular and cellular mechanisms responsible for the clinical heterogeneity of B cell NHL are largely unknow…”
Background
Complete remission of primary hepatic lymphoma in a patient with human immunodeficiency virus
Widjaja, D. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i2.186 · Cited by 7
Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia
Patel, M. I. (2016) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-016-0329-y · Cited by 6
Childhood infectious diseases and risk of non‐Hodgkin's lymphoma according to the WHO classification: A reanalysis of the Italian multicenter case–control study
Parodi, S., Costantini, A. S., Crosignani, P., Fontana, A., Miligi, L., Nanni, O., Piro, S., Ramazzotti, V., Rodella, S., Tumino, R., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32393 · Cited by 6
“All diagnoses of NHL were revised by a single pathologist and classified according to the working formulation (WF)15 and immunophenotype.16 For the purpose of our study and of a previous investigation on dietary habits,17 each case was reclassified by a trained epidemiologist of the Liguria Cancer Registry using the m…”
MethodSelf-citation

Authors: Morton, L. M., Turner, J. J., Cerhan, J. R., Linet, M. S., Treseler, P. A., Clarke, C. A., Jack, A., Cozen, W., Maynadié, M., Spinelli, J. J., Costantini, A. S., Rüdiger, T., Scarpa, A., Zheng, T., & Weisenburger, D. D.
Affiliations: National Institutes of Health (US)
St Vincent's Hospital Sydney (AU)
Mayo Clinic (US)
University of California, San Francisco (US)
Cancer Prevention Institute of California (US)
National Health Service (GB)
University of Southern California (US)
CHU Dijon Bourgogne (FR)
BC Cancer Agency (CA)
Occupational and Environmental Epidemiology Unit, Center for Study and Prevention of Cancer, Scientific Institute of Tuscany, Florence, Italy;
University of Würzburg (DE)
University of Verona (IT)
Yale University (US)
University of Nebraska Medical Center (US)
ORCID: Morton, Lindsay M.
Turner, Jennifer J.
Cerhan, James R.
Linet, Martha S.
Clarke, Christina A.
Jack, Andrew
Cozen, Wendy
Maynadié, Marc
Costantini, Adele Seniori
Rüdiger, Thomas
Scarpa, Aldo
Weisenburger, Dennis D.
Venue: Blood
Publisher: American Society of Hematology
Published: 2007-07-15
Volume: 110
Issue: 2
Pages: 695-708
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2006-11-051672
PMC: PMC1924473
OpenAlex: W2061918976
Cited by: 387
References: 58
Citations by year: 2026: 4 · 2025: 6 · 2024: 8 · 2023: 17 · 2022: 14 · 2021: 16 · 2020: 14 · 2019: 14 · 2018: 14 · 2017: 15 · 2016: 23 · 2015: 30 · 2014: 45 · 2013: 28 · 2012: 34
FWCI: 20.35
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Blood (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Cancer Institute (P50CA97274, R01CA092153, R01CA062006, N01-CN-35136, CA 62006-05, R01CA92153, P50CA097274)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
Keywords: lymphoid malignancies, lymphoma subtypes, classification standardization, lymphoid leukemia, ICD-O-3, WHO classification of lymphoid neoplasms, REAL classification, Working Formulation, lymphoma etiology
MeSH terms: Europe, Hodgkin Disease, Humans, Lymphoma, Lymphoma, Non-Hodgkin, North America, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks